Sign In
Buy CLOV
$3.65
-0.0800 (-2.14%)
At Close: Jun 03, 2026
Is Clover Health Investments (CLOV) Outperforming Other Medical Stocks This Year?
10:41am, Wednesday, 24'th Sep 2025
Here is how Clover Health Investments, Corp. (CLOV) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
Fast-paced Momentum Stock Clover Health Investments (CLOV) Is Still Trading at a Bargain
09:51am, Tuesday, 23'rd Sep 2025
Clover Health Investments (CLOV) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently bu
Dr. Duncan's appointment to this prestigious role recognizes his extraordinary contributions to the actuarial profession and healthcare innovation over three decades Dr. Duncan's appointment to this p
Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
08:30am, Tuesday, 16'th Sep 2025
Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements Clover Health Continues to Invest in Streamlinin
WASHINGTON, D.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) – Clover Health CEO Andrew Toy today had
Here's Why You Should Add CLOV Stock to Your Portfolio Now
10:50am, Friday, 29'th Aug 2025
Clover's strong membership growth, rising revenues, and first-half EBITDA profitability highlight its tech-driven Medicare Advantage edge.
Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now
10:56am, Thursday, 21'st Aug 2025
Clover Health Investments (CLOV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agre
Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential
10:29am, Monday, 11'th Aug 2025
While Clover Health's Q2 earnings showed continued member and revenue growth, it dropped 30% since then due to higher medical costs that impacted all MA plan providers. Clover Health still maintains i
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View
11:41am, Wednesday, 06'th Aug 2025
Clover Health's Q2 revenues rise 34%, but raised Insurance BER guidance and margin pressures cause shares to tumble post-earnings.
Clover Health (CLOV) Q2 Sales Up 34%
09:43pm, Tuesday, 05'th Aug 2025
Clover Health (CLOV) Q2 Sales Up 34%
Clover Health Investments, Corp. (CLOV) Q2 2025 Earnings Call Transcript
08:39pm, Tuesday, 05'th Aug 2025
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Andrew Toy - Co-Founder, CEO & Director Peter J. Kuipers - Chief Financi
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates
07:06pm, Tuesday, 05'th Aug 2025
Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.03 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.01 per share a year ago.
Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth
04:05pm, Tuesday, 05'th Aug 2025
Second quarter 2025 Medicare Advantage membership of 106,323, up 32% year-over-year Second quarter 2025 Total revenues of $478 million, up 34% year-over-year Second quarter 2025 profitability metrics
New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) di
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
09:50am, Friday, 01'st Aug 2025
CLOV's second-quarter results are likely to reflect strong Medicare Advantage membership growth and expansion and deeper integration of Clover Assistant.
